Intimation of closure of Trading Window for the quarter ended 31st December, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs Limited has informed BSE that its trading window will be closed for all designated persons and their immediate relatives from January 1, 2026, until 48 hours after the announcement of unaudited financial results for the third quarter and nine months ended December 31, 2025. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015, to prevent insiders from trading while they may have access to unpublished financial information. The company stated that the board meeting date for considering the Q3 results will be communicated separately. The intimation was signed by Venkatesh Achanta, Company Secretary & Compliance Officer, on December 23, 2025.
This is a standard regulatory filing and does not signal any fundamental change. However, it tells shareholders that Q3 FY26 results are expected to be announced in early-to-mid January 2026, and the stock may see some movement around that announcement.